Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 17

    COVID-19: USFDA updates about supply chain effect on medicines, devices and PPE

    COVID-19: USFDA updates about supply chain effect on medicines, devices and PPE

    Medical Dialogues Bureau1 March 2020 2:45 PM IST
    A manufacturer has alerted that a shortage of a human drug that was recently added to the drug shortages list.
    FDA Advisory approves Lillys CYRAMZA (ramucirumab) for type of lung Cancer

    FDA Advisory approves Lilly's CYRAMZA (ramucirumab) for type of lung Cancer

    Medical Dialogues Bureau1 March 2020 2:00 PM IST
    The ODAC considered the safety and efficacy data from the Phase 3 RELAY trial, which is the basis for the CYRAMZA supplemental Biologics License...
    Biohaven Receives Fda Approval for acute migraine drug

    Biohaven Receives Fda Approval for acute migraine drug

    Medical Dialogues Bureau1 March 2020 12:30 PM IST
    A single quick-dissolving tablet of NURTEC ODT can provide fast pain relief and return patients to normal function within one hour, and deliver...
    Merck, AMCM collaborates for 3D Printing of Tablets

    Merck, AMCM collaborates for 3D Printing of Tablets

    Medical Dialogues Bureau1 March 2020 10:30 AM IST
    3D printing allows for API (active pharmaceutical development) formulation to be scalable while avoiding costly reformulations throughout the entire...
    Sandoz commits to keep prices of essential medicines stable amidst coronavirus fear

    Sandoz commits to keep prices of essential medicines stable amidst coronavirus fear

    Medical Dialogues Bureau1 March 2020 10:00 AM IST
    Germany: Sandoz the provider of off-patent antibiotic medicines worldwide, made a public commitment to ensure stable pricing for a basket of essential...
    Dr Reddys Laboratories launches generic of Naproxen, Esomeprazole Magnesium Delayed-Release Tablets

    Dr Reddy's Laboratories launches generic of Naproxen, Esomeprazole Magnesium Delayed-Release Tablets

    Medical Dialogues Bureau29 Feb 2020 1:30 PM IST
    Dr Reddy's Naproxen and Esomeprazole Magnesium Delayed-Release Tablets are available in 375 mg/20 mg and 500 mg/20 mg tablets in bottle count sizes of...
    Biocon Small Molecules API Manufacturing Facility Completes Post -Approval and GMP USFDA Inspection

    Biocon Small Molecules API Manufacturing Facility Completes Post -Approval and GMP USFDA Inspection

    Medical Dialogues Bureau29 Feb 2020 11:35 AM IST
    New Delhi: Drug API maker, Biocon has informed that the U.S. Food and Drug Administration (FDA) conducted a Post-Approval and GMP inspection of Small...
    Spanish Pharmaceutical Leader Ferrer Partners with Wellthy Therapeutics

    Spanish Pharmaceutical Leader Ferrer Partners with Wellthy Therapeutics

    Medical Dialogues Bureau29 Feb 2020 10:45 AM IST
    New Delhi: Wellthy Therapeutics DTx solution has emerged global winner at Ferrer's 4 Future Innovation Challenge The Ferrer 4 Future...
    Mylan warns of possible drug shortages, financial hit due to coronavirus

    Mylan warns of possible drug shortages, financial hit due to coronavirus

    Medical Dialogues Bureau29 Feb 2020 9:30 AM IST
    Although heavily reliant on China, the company said it was better positioned against the impact of the outbreak compared to its peers due to its...
    Glenmark Pharmaceuticals ,Hikma enter join hands for commercializing Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in US

    Glenmark Pharmaceuticals ,Hikma enter join hands for commercializing Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in US

    Medical Dialogues Bureau28 Feb 2020 2:42 PM IST
    Ryaltris™ [olopatadine hydrochloride (665 mcg) and mometasone furoate (25 mcg)], developed by Glenmark, is a novel fixed-dose combination nasal spray...
    Sanjeev Narula CFO Pfizer Upjohn  appointed as incoming CFO of Viatris

    Sanjeev Narula CFO Pfizer Upjohn appointed as incoming CFO of Viatris

    Medical Dialogues Bureau28 Feb 2020 1:45 PM IST
    Viatris is the new company that will result from the planned combination of Mylan and Upjohn
    GeneTex Launches Novel Antibody for pancreatic tumor

    GeneTex Launches Novel Antibody for pancreatic tumor

    Medical Dialogues Bureau28 Feb 2020 9:15 AM IST
    Irvine: GeneTex, a research antibody manufacturing company, has announced the release of a novel recombinant rabbit monoclonal RAS (G12D mutant)...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok